<DOC>
	<DOCNO>NCT01040884</DOCNO>
	<brief_summary>This prospective , single-arm , single-center , open-label study evaluate preliminary safety accuracy ActiSight™ Needle Guidance System patient undergo CT-guided percutaneous aspiration RF Ablations The procedure perform trained physician . Subjects screen inclusion study . Following signing informed consent , screen procedure perform include demographic medical history , vital sign , anthropometrics ) , chest radiography , applicable CT scanning , blood sample coagulation index ( PT , APTT ) , applicable , pregnancy test woman child-bearing potential . Within 18-day screening period , eligible subject enrol study undergo percutaneous aspiration percutaneous biopsy RF ablation utilize ActiSight™ Needle Guidance system use CT guide needle . Subjects followed-up least one hour clinic safety preliminary accuracy evaluation . An erect chest radiograph perform within 90 minute observation chest aspiration perform detect majority post procedure pneumothoraces biopsy chest . Post procedural CT perform accord physician 's consideration . ** Note ** If complication observe use ActiSight System , investigator revert use standard procedure .</brief_summary>
	<brief_title>Safety And Accuracy Study Of The Actisight™ Needle Guidance System In Patients Undergoing CT-Guided Procedures</brief_title>
	<detailed_description>Within 18-day screening period , eligible subject enrol study undergo percutaneous aspiration percutaneous biopsy RF ablation utilize ActiSight™ Needle Guidance system use CT guide needle . Subjects followed-up least one hour clinic safety preliminary accuracy evaluation . An erect chest radiograph perform within 90 minute observation chest aspiration perform detect majority post procedure pneumothoraces biopsy chest . Post procedural CT perform accord physician 's consideration . ** Note ** If complication observe use ActiSight System , investigator revert use standard procedure .</detailed_description>
	<criteria>Male female subject , 18 year age old time enrollment Subjects meet medical condition percutaneous aspiration/biopsy safe path lesion INR &lt; 1.4 Written inform consent participate study Ability comply requirement study procedure Hemophilia , thrombocytopenia , coagulopathy , elevate risk bleed abnormal clotting Use Aspirin similar antithrombotic medication Pulmonary hypertension , heart failure , renal failure , blood dyscrasia Subjects tolerate mild sedation Subjects follow laboratory value , unless approve hematologist : Platelet count &lt; 60,000/mL APTT &gt; 39 sec PT &gt; 15 sec , INR &gt; 1.4 Pregnancy lactation Patient unable comply requirement procedure , i.e . hold breath Participation investigational trial within 30 day enrollment Any form substance abuse ( include drug alcohol abuse ) , psychiatric disorder , chronic condition could , opinion investigator , interfere conduct study . Subjects uncooperative follow instruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>